Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Donepezil Double Blind Trial for ECT Memory Disfunction

NCT00465283 is registered in ClinicalTrials.gov with BeerYaakov Mental Health Center as lead sponsor.

NCT NCT00465283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00465283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Donepezil Double Blind Trial for ECT Memory Disfunction
Lead sponsor
BeerYaakov Mental Health Center
Phase
Phase 4
Overall status
Unknown status
Start date
May 31, 2007
Completion date
January 31, 2010
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia, schizophreniform disorder